Home / Inspections / 567584

FDA Inspection 567584 — Gemini Pharmaceuticals, Inc.

Gemini Pharmaceuticals, Inc. — FEI 2432926

The FDA completed an inspection of Gemini Pharmaceuticals, Inc. on February 5, 2009 in Commack, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Veterinary.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 5, 2009
Fiscal Year
2009
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
Commack, NY (United States)

Facility

Other inspections at this facility

  • 1317530 (VAI Fri May 15 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1175407 (NAI Tue Jul 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1064447 (NAI Thu Aug 23 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1041525 (VAI Fri Feb 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 936886 (VAI Tue Jun 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources